Birchview Capital’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,000
Closed -$726K 60
2022
Q3
$726K Hold
10,000
0.51% 32
2022
Q2
$680K Buy
10,000
+2,000
+25% +$144K 0.49% 30
2022
Q1
$725K Buy
8,000
+1,000
+14% +$81.8K 0.52% 34
2021
Q4
$639K Hold
7,000
0.41% 40
2021
Q3
$568K Hold
7,000
0.39% 37
2021
Q2
$653K Hold
7,000
0.39% 38
2021
Q1
$749K Hold
7,000
0.44% 34
2020
Q4
$611K Hold
7,000
0.35% 37
2020
Q3
$483K Sell
7,000
-3,000
-30% -$193K 0.32% 31
2020
Q2
$484K Buy
+10,000
New +$478K 0.29% 36

Other funds holding NARI

Birchview Capital's NARI Position: Q4 2022 in Review

Birchview Capital sold out of Inari Medical, Inc. Common Stock (NARI) in Q4 2022, closing a stake of 10,000 shares — an estimated $726K sold.

Birchview Capital first reported a position in NARI in Q2 2020 and held it in 10 quarters. The position peaked at $749K in Q1 2021. 246 funds tracked by Wall St. Rank hold NARI as of Q4 2022.

  • Birchview Capital reported no remaining Inari Medical, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Birchview Capital sold 10,000 Inari Medical, Inc. Common Stock shares in Q4 2022, an estimated $726K.
  • Birchview Capital first reported a position in Inari Medical, Inc. Common Stock in Q2 2020 and held it in 10 quarters.
  • Birchview Capital's Inari Medical, Inc. Common Stock position peaked at $749K in Q1 2021.
  • 246 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q4 2022.

Based on Birchview Capital's 13F filing for Q4 2022, filed 3 Feb 2023.